The news that was released was certainly positive, but there is no reason that talk of more trials should move the SP up (or down). "Starkist wants tuna that tastes great, not tuna with great taste." We could talk about another 100 possible indications and trials, but without the results we believe are coming from Brazil that should lead to an approval, all else is just basically "The pizza smells great, it's the delivery that we're waiting on." And the BLA stuff? "Wolf! Wolf!" I'll believe it when I see it.

Stay positive. We'll know about Brazil soon enough, if the enrollment is going as we hope it is. Hoping to add more in the next week.